Overcoming the evolution of cancer 14 Oct 2016 Cancer evolution can lead to the emergence of drug resistance, so the ICR and The Royal Marsden are working to unravel cancer's complexity and open up new approaches to treatment. Find out more Show/Hide
Pinpointing the first founder mutations that lead to leukaemia 12 Dec 2013 Professors Mel Greaves and Richard Houlston were able to identify the exact mutations that kick-start cancer, potentially enabling more effective targeted therapies. Find out more Show/Hide
Kinase inhibitors: the science behind a revolution 19 Jul 2013 A little more than a decade ago, the prospects for people with chronic myelogenous leukaemia (CML) were rather bleak. Common treatments included high-risk bone marrow transplants, which required at least four weeks in hospital and often led to severe complications down the line. Find out more Show/Hide